Hologic (HOLX) Q4 Earnings Miss Estimates

Company Performance - Hologic reported quarterly earnings of $1.01 per share, slightly missing the Zacks Consensus Estimate of $1.02 per share, but showing an increase from $0.89 per share a year ago, resulting in an earnings surprise of -0.98% [1] - The company posted revenues of $987.9 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 0.88% and increasing from $945.3 million year-over-year [2] - Over the last four quarters, Hologic has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Future Outlook - The immediate price movement of Hologic's stock will depend on management's commentary during the earnings call and the company's earnings outlook [3][4] - The current consensus EPS estimate for the upcoming quarter is $1.04 on revenues of $1.05 billion, and for the current fiscal year, it is $4.36 on revenues of $4.23 billion [7] - The estimate revisions trend for Hologic is currently mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Medical - Instruments industry, to which Hologic belongs, is currently in the top 32% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]